571 related articles for article (PubMed ID: 27447749)
1. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
2. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
[TBL] [Abstract][Full Text] [Related]
3. miR-199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1.
Hu S; Zhou Q; Lu Q; Guo X; Wang Y; Duan YX
Kaohsiung J Med Sci; 2023 Dec; 39(12):1178-1189. PubMed ID: 37772770
[TBL] [Abstract][Full Text] [Related]
4. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
6. MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression.
Li JZ; Li J; Wang HQ; Li X; Wen B; Wang YJ
Biochem Biophys Res Commun; 2017 Jan; 482(4):1381-1386. PubMed ID: 27956179
[TBL] [Abstract][Full Text] [Related]
7. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Liu C; Kelnar K; Liu B; Chen X; Calhoun-Davis T; Li H; Patrawala L; Yan H; Jeter C; Honorio S; Wiggins JF; Bader AG; Fagin R; Brown D; Tang DG
Nat Med; 2011 Feb; 17(2):211-5. PubMed ID: 21240262
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
9. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
10. miRNA-708 control of CD44(+) prostate cancer-initiating cells.
Saini S; Majid S; Shahryari V; Arora S; Yamamura S; Chang I; Zaman MS; Deng G; Tanaka Y; Dahiya R
Cancer Res; 2012 Jul; 72(14):3618-30. PubMed ID: 22552290
[TBL] [Abstract][Full Text] [Related]
11. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
Song XL; Huang B; Zhou BW; Wang C; Liao ZW; Yu Y; Zhao SC
Biomed Pharmacother; 2018 Mar; 99():369-374. PubMed ID: 29358129
[TBL] [Abstract][Full Text] [Related]
12. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
[TBL] [Abstract][Full Text] [Related]
14. Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Yan X; Tang B; Chen B; Shan Y; Yang H;
Elife; 2019 Mar; 8():. PubMed ID: 30860027
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
16. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.
Henry JC; Park JK; Jiang J; Kim JH; Nagorney DM; Roberts LR; Banerjee S; Schmittgen TD
Biochem Biophys Res Commun; 2010 Dec; 403(1):120-5. PubMed ID: 21055388
[TBL] [Abstract][Full Text] [Related]
17. NUMB suppression by miR-9-5P enhances CD44
Wang X; Cai J; Zhao L; Zhang D; Xu G; Hu J; Zhang T; Jin M
Sci Rep; 2021 May; 11(1):11210. PubMed ID: 34045601
[TBL] [Abstract][Full Text] [Related]
18. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
19. miR-197-3p Represses the Proliferation of Prostate Cancer by Regulating the VDAC1/AKT/β-catenin Signaling Axis.
Huang Q; Ma B; Su Y; Chan K; Qu H; Huang J; Wang D; Qiu J; Liu H; Yang X; Wang Z
Int J Biol Sci; 2020; 16(8):1417-1426. PubMed ID: 32210729
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
